SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3311OCRX (not on your list) made a new 52-wk low today, although it closed a few cenDewDiligence_on_SI-1/13/2016
3310pharma 52 wk lows: [graphic][graphic][graphic][graphic] ANIP ANI PharmaceuticaThe Ox11/13/2016
330952 wk lows: [graphic][graphic][graphic][graphic] ICPT Intercept PharmaceuticalThe Ox11/13/2016
3308The best is: not to say anything!Miljenko Zuanic-1/13/2016
3307Adaptimmune (ADAP) also whacked 15% on no news, bouncing an eensy bit as I type.tuck-1/13/2016
3306Neuralstem (CUR) off 25%. Don't follow it, but apparently it said somethingtuck-1/13/2016
3305OCRX -21% on no news. Thinly-traded.DewDiligence_on_SI-1/13/2016
3304CARA off 15% on news. Been trying to catch that falling knife, lost a finger sotuck-1/13/2016
3303I think either general funds dumped all bios or a fund blew up. Jon PS. A comRobohogs-1/12/2016
3302But we got one! Bids, we actually have bids. :-) (sorry for the chatter)scaram(o)uche-1/12/2016
3301Hey Jon. I don't expect one. Ride overweights? We should all ask Andy Bioscaram(o)uche-1/11/2016
3300IF there is going to be a JPM effect, it usually starts Day 2. IF.Robohogs-1/11/2016
3299Price:book under 3. Throw traditional metrics out the door, as Hillary et al. ascaram(o)uche11/11/2016
3298Bluebird (BLUE) off 19% on delay on news that there will be no update on BB305 utuck-1/11/2016
3297GNVC down 60% On January 8, 2016, Novartis notified GenVec that it was pausintom pope-1/11/2016
3296Epizyme, Inc. ( EPZM), a clinical stage biopharmaceutical company creatingJulius Wong-1/7/2016
3295ACAD: Secondary of 10M+ shares at $29/share to yield about $300M for the companyIan@SI-1/7/2016
3294Acadia (ACAD) off 15.1% amid the general carnage. Did not see specific news, butuck-1/7/2016
3293CMRX 70% on trial failure.Robohogs-12/28/2015
3292KaloBios chief Shkreli arrested on securities fraud charge; shares plunge 50% prJulius Wong-12/17/2015
3291Who did the graphic for this thread??? Stefan? VERY cool. :-)scaram(o)uche-12/14/2015
3290NEOT -77%/AH on dual phase-3 failures: siliconinvestor.com Now down 88%(!)DewDiligence_on_SI-12/14/2015
3289BIND off 25% to $2.63 on about 4X average volume. News released today probably apgo-neil-12/14/2015
3288Atara Biotherapeutics (ATRA) stops development of kidney drugJulius Wong-12/14/2015
3287PBYI -24% since Wednesday's close on SABCS updates. DewDiligence_on_SI-12/11/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News